Literature DB >> 3031655

Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases.

M Klagsbrun, S Smith, R Sullivan, Y Shing, S Davidson, J A Smith, J Sasse.   

Abstract

Basic fibroblast growth factor (FGF) was purified by heparin-Sepharose chromatography from two sources, brain and hepatoma cells. Brain cell-derived basic FGF (brFGF) and hepatoma cell-derived basic FGF (heFGF) were found to exist in multiple forms whose molecular weights depended on whether they were extracted from their respective tissue or cells at neutral or acid pH. When extracted at pH 7.0 brFGF and heFGF comigrated on NaDodSO4/PAGE with a Mr of approximately 18,400. When extracted at pHs 3.5-4.5, acid proteinases cleaved brFGF and heFGF to lower molecular weight forms but to different extents. brFGF was cleaved to a Mr 18,000 form at acid pH by a brain-derived acid proteinase that could be inhibited by pepstatin. heFGF was cleaved mostly to a Mr 16,500 form at acid pH by a hepatoma cell-derived acid proteinase that was inhibited by leupeptin. Electrophoretic transfer blot analysis using site-specific anti-FGF antibodies suggested that the cleavages occurred at the amino-terminal ends of brFGF and heFGF. Cleavage to lower molecular weight forms of brFGF and heFGF did not affect growth factor activity or chromatographic behavior on heparin-Sepharose columns.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031655      PMCID: PMC304536          DOI: 10.1073/pnas.84.7.1839

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor.

Authors:  J A Abraham; A Mergia; J L Whang; A Tumolo; J Friedman; K A Hjerrild; D Gospodarowicz; J C Fiddes
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

2.  Purification and characterization of heparin-binding endothelial cell growth factors.

Authors:  R Lobb; J Sasse; R Sullivan; Y Shing; P D'Amore; J Jacobs; M Klagsbrun
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

3.  Isolation of an amino terminal extended form of basic fibroblast growth factor.

Authors:  N Ueno; A Baird; F Esch; N Ling; R Guillemin
Journal:  Biochem Biophys Res Commun       Date:  1986-07-31       Impact factor: 3.575

Review 4.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

5.  Simultaneous localization of multiple tissue antigens using the peroxidase-labeled antibody method: a study on pituitary glands of the rat.

Authors:  P K Nakane
Journal:  J Histochem Cytochem       Date:  1968-09       Impact factor: 2.479

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage.

Authors:  M Klagsbrun; R Langer; R Levenson; S Smith; C Lillehei
Journal:  Exp Cell Res       Date:  1977-03-01       Impact factor: 3.905

8.  Purification of the fibroblast growth factor activity from bovine brain.

Authors:  D Gospodarowicz; H Bialecki; G Greenburg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

9.  Transforming growth factors from a human tumor cell: characterization of transforming growth factor beta and identification of high molecular weight transforming growth factor alpha.

Authors:  L L Dart; D M Smith; C A Meyers; M B Sporn; C A Frolik
Journal:  Biochemistry       Date:  1985-10-08       Impact factor: 3.162

10.  Evidence for pro-beta-nerve growth factor, a biosynthetic precursor to beta-nerve growth factor.

Authors:  E A Berger; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

View more
  30 in total

1.  Heparin-binding growth factors and their receptors.

Authors:  B B Olwin
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Human dermal fibroblasts express multiple bFGF and aFGF proteins.

Authors:  L L Root; G D Shipley
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

3.  Purification and characterization of heparin-binding growth factors from porcine uterus.

Authors:  D R Brigstock; R B Heap; P J Barker; K D Brown
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

Review 4.  Basic fibroblast growth factor and its relation to angiogenesis in normal and neoplastic tissue.

Authors:  L Schweigerer
Journal:  Klin Wochenschr       Date:  1988-04-15

Review 5.  Interaction of interferon with other cytokines.

Authors:  G Opdenakker; Y Cabeza-Arvelaiz; J Van Damme
Journal:  Experientia       Date:  1989-06-15

Review 6.  Fibroblast (heparin-binding) growing factors in neuronal development and repair.

Authors:  L W Haynes
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

7.  Immunolocalization of fibroblast growth factor-2 (FGF-2) in the developing root and supporting structures of the murine tooth.

Authors:  A K Madan; Beverley Kramer
Journal:  J Mol Histol       Date:  2005-03       Impact factor: 2.611

8.  High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons.

Authors:  H Prats; M Kaghad; A C Prats; M Klagsbrun; J M Lélias; P Liauzun; P Chalon; J P Tauber; F Amalric; J A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.

Authors:  J D Zhang; L S Cousens; P J Barr; S R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 10.  Fibroblast growth factor-2 and cardioprotection.

Authors:  Elissavet Kardami; Karen Detillieux; Xin Ma; Zhisheng Jiang; Jon-Jon Santiago; Sarah K Jimenez; Peter A Cattini
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.